(Q67685133)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1706642%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

title

Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1706642%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference

1 reference

3 November 2022

1 reference

3 November 2022

author name string

A. Hekman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706642

3 November 2022

A. Honselaar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706642

3 November 2022

W. M. Vuist

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706642

3 November 2022

J. J. Sein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706642

3 November 2022

S. Rodenhuis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706642

3 November 2022

W. W. ten Bokkel Huinink

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706642

3 November 2022

R. Somers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706642

3 November 2022

P. Rümke

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706642

3 November 2022

C. J. Melief

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1706642

3 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1706642

3 November 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1706642%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

http://link.springer.com/content/pdf/10.1007/BF01741331.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01741331/fulltext.html

3 November 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01741331

3 November 2022

1 reference

Cancer Immunology, Immunotherapy

3 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1706642%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1706642%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1706642%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

364-372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1706642%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01741331

16 September 2019

exact match

0 references

cites work

Biological response modifiers: the new immunotherapy.

1 reference

12 December 2020

Serotherapy of cancer

1 reference

12 December 2020

Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis

1 reference

12 December 2020

Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma

1 reference

12 December 2020

CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2

1 reference

12 December 2020

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

12 December 2020

Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2.

1 reference

12 December 2020

Monoclonal antibody therapy of lymphoid malignancy

1 reference

12 December 2020

Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas

1 reference

12 December 2020

Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation.

1 reference

12 December 2020

Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity

1 reference

12 December 2020

Murine monoclonal IgG3 to human colorectal tumor-associated antigens: enhancement of antibody-dependent cell-mediated cytotoxicity by interleukin 2

1 reference

12 December 2020

Fluctuation of the number of CD-1(T6)-positive dendritic cells, presumably Langerhans cells, in the nasal mucosa of patients with an isolated grass-pollen allergy before, during, and after the grass-pollen season

1 reference

12 December 2020

Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin

1 reference

12 December 2020

Immunobiologic differences between normal and leukemic human B-cell precursors

1 reference

12 December 2020

Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.

1 reference

12 December 2020

Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodies

1 reference

12 December 2020

Mouse monoclonal antibodies against the idiotype of human B cell non-Hodgkin lymphomas: production, characterization and use to monitor the progress of disease

1 reference

12 December 2020

A clinical trial of anti-idiotype therapy for B cell malignancy

1 reference

12 December 2020

Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody

1 reference

12 December 2020

Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies

1 reference

12 December 2020

Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodies.

4

1 reference

Regulatory role of CD19 molecules in B-cell activation and differentiation

3 November 2022

5

1 reference

The surface antigens of human B lymphocytes

3 November 2022

32

1 reference